Medicus Pharma (MDCXW) Shares Outstanding (Diluted Average) (2023 - 2025)
Medicus Pharma (MDCXW) reported Shares Outstanding (Diluted Average) of $17.3 million for Q4 2025, up 79.68% on a YoY basis from $9.6 million in Q4 2024, and down 7.23% quarter-over-quarter from $18.6 million in Q3 2025.
Medicus Pharma (MDCXW) Shares Outstanding (Diluted Average) (2023 - 2025) Analysis & Trends
Medicus Pharma has reported Shares Outstanding (Diluted Average) for 3 years, with the latest figure at $17.3 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 79.68% year-over-year to $17.3 million; the trailing twelve-month figure through Dec 2025 stood at $17.3 million (up 79.68% YoY), and the FY2025 full-year result was $17.3 million, up 79.68% from the prior year.
- Shares Outstanding (Diluted Average) for Q4 2025 stood at $17.3 million, down from $18.6 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $18.6 million in Q3 2025, with the low at $3.5 million in Q4 2023.
- Historically, Shares Outstanding (Diluted Average) has averaged $11.2 million across 3 years, with a median of $9.6 million in 2024.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Diluted Average) jumped 176.45% — and 2025, when it soared 51.55%.
- Medicus Pharma's Shares Outstanding (Diluted Average) stood at $3.5 million in 2023, then jumped by 176.45% to $9.6 million in 2024, then surged by 79.68% to $17.3 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $17.3 million (Q4 2025), $18.6 million (Q3 2025), and $14.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 895.90 Mn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 2.45 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 1.77 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | - |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 1.25 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 5.73 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | - |
| 10 | Medicus Pharma | - | - | - | 17.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.28 Mn |
| Sep 30, 2025 | 18.63 Mn |
| Jun 30, 2025 | 14.28 Mn |
| Mar 31, 2025 | 12.24 Mn |
| Dec 31, 2024 | 9.62 Mn |
| Sep 30, 2024 | 9.04 Mn |
| Jun 30, 2024 | 8.12 Mn |
| Mar 31, 2024 | 8.08 Mn |
| Dec 31, 2023 | 3.48 Mn |